Qsymia 3.75 Mg/23 Mg Capsules Pakistan

Qsymia 3.75 Mg/23 Mg Capsules Pakistan

Qsymia 3.75 Mg/23 Mg Capsules Pakistan  Qsymia 3.75 mg/23 mg capsules are the lowest dosage strength of this prescription medication, designed for weight management in adults. The capsules combine two active ingredients, phentermine and topiramate, in an extended-release formulation. This initial dose is used as a starting point in a titration schedule to help assess tolerance and minimize potential side effects.

Active Ingredients

1. Phentermine (3.75 mg): A central nervous system stimulant that acts as an appetite suppressant. It increases the release of norepinephrine, which helps reduce hunger sensations and caloric intake.
2. Topiramate (23 mg): An anticonvulsant medication with weight loss properties. Topiramate helps promote feelings of fullness, decreases appetite, and may alter taste, making certain foods less appealing.

Indications

• A body mass index (BMI) of 30 kg/m² or greater (obesity).

Dosage and Administration

The 3.75 mg/23 mg dosage is typically the starting dose in the Qsymia treatment regimen.After two weeks, the dose is often increased to 7.5 mg/46 mg, depending on individual response and tolerability.

Potential Side Effects

Common side effects associated with Qsymia may include:

• Dry mouth
• Tingling sensations in the hands and feet (paresthesia)
• Constipation
• Dizziness
• Insomnia
• Mood or behavior changes
• Increased heart rate
• Metabolic acidosis

Precautions and Contraindications

• Drug Interactions: Qsymia may interact with other medications, including monoamine oxidase inhibitors (MAOIs), certain antidepressants, and other drugs affecting the central nervous system.

Conclusion

Qsymia 3.75 mg/23 mg capsules serve as the introductory dosage for patients starting on this weight management medication. The combination of phentermine and topiramate in Qsymia provides a dual approach to weight loss by suppressing appetite and enhancing satiety.